Calamos Advisors LLC lowered its stake in shares of IMS Health Holdings Inc. (NYSE:IMS) by 33.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 906,337 shares of the company’s stock after selling 465,169 shares during the period. Calamos Advisors LLC’s holdings in IMS Health Holdings were worth $22,985,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in the stock. Artemis Investment Management LLP bought a new position in shares of IMS Health Holdings during the second quarter worth $17,952,000. Pitcairn Co. increased its position in shares of IMS Health Holdings by 7.5% in the second quarter. Pitcairn Co. now owns 8,937 shares of the company’s stock worth $226,000 after buying an additional 625 shares in the last quarter. Shell Asset Management Co. increased its position in shares of IMS Health Holdings by 520.7% in the second quarter. Shell Asset Management Co. now owns 47,919 shares of the company’s stock worth $1,215,000 after buying an additional 40,199 shares in the last quarter. CIBC World Markets Inc. bought a new position in shares of IMS Health Holdings during the second quarter worth $456,000. Finally, LS Investment Advisors LLC increased its position in shares of IMS Health Holdings by 14.0% in the second quarter. LS Investment Advisors LLC now owns 4,982 shares of the company’s stock worth $126,000 after buying an additional 611 shares in the last quarter. 90.25% of the stock is owned by hedge funds and other institutional investors.
Shares of IMS Health Holdings Inc. (NYSE:IMS) traded down 0.26% on Wednesday, reaching $30.53. 607,489 shares of the company were exchanged. The company has a market cap of $10.05 billion, a price-to-earnings ratio of 74.10 and a beta of 0.85. The company’s 50-day moving average price is $29.69 and its 200 day moving average price is $27.23. IMS Health Holdings Inc. has a 12 month low of $22.36 and a 12 month high of $31.59.
IMS Health Holdings (NYSE:IMS) last posted its earnings results on Wednesday, July 27th. The company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.03. The firm earned $802 million during the quarter, compared to analysts’ expectations of $796.93 million. IMS Health Holdings had a net margin of 4.45% and a return on equity of 30.61%. The business’s revenue for the quarter was up 112.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.37 earnings per share. On average, equities research analysts expect that IMS Health Holdings Inc. will post $1.64 EPS for the current year.
A number of equities analysts have weighed in on the stock. TheStreet downgraded shares of IMS Health Holdings from a “buy” rating to a “hold” rating in a research note on Monday, August 29th. Zacks Investment Research raised shares of IMS Health Holdings from a “sell” rating to a “hold” rating and set a $34.00 target price for the company in a research note on Friday, July 29th. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. IMS Health Holdings presently has an average rating of “Buy” and a consensus price target of $31.00.
IMS Health Holdings Company Profile
IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
Want to see what other hedge funds are holding IMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IMS Health Holdings Inc. (NYSE:IMS).
Receive News & Ratings for IMS Health Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMS Health Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.